Back to funds
View filing
Artia Global Partners LP
hedge fundUpdated 27 days agoManaged by Artia Global Partners Lp • Latest filing Q2 2026
Portfolio value
$541.9M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
97.1%
Weight of largest holdings
Annualized return
21.0%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $270.6M |
| Q2 2023 | $290.1M |
| Q3 2023 | $240.6M |
| Q4 2023 | $343.7M |
| Q1 2024 | $497.5M |
| Q2 2024 | $517.3M |
| Q3 2024 | $366.9M |
| Q4 2024 | $279.8M |
| Q1 2025 | $395.1M |
| Q2 2025 | $415.6M |
| Q3 2025 | $630.9M |
| Q4 2025 | $705.8M |
| Q1 2026 | $499.4M |
| Q2 2026 | $541.9M |
Top holdings
48 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AAVXF ABIVAX SA | $68.8M | 516.4K | 12.70% | — |
| 2 | I INSM INSMED INC | $62.8M | 589.1K | 11.59% | — |
| 3 | T TRVI TREVI THERAPEUTICS INC | $41.2M | 2.21M | 7.61% | — |
| 4 | B BTSGU BRIGHTSPRING HEALTH SVCS INC | $36.1M | 517.3K | 6.66% | — |
| 5 | R RVMDW REVOLUTION MEDICINES INC | $34.7M | 185.4K | 6.41% | — |
| 6 | A ARGX ARGENX SE | $27.6M | 29.7K | 5.09% | — |
| 7 | A ALKS ALKERMES PLC | $23.5M | 449.0K | 4.34% | — |
| 8 | T TVTX TRAVERE THERAPEUTICS INC | $19.3M | 339.0K | 3.55% | — |
| 9 | A AZN ASTRAZENECA PLC | $18.7M | 98.4K | 3.44% | — |
| 10 | N NAMSW NEWAMSTERDAM PHARMA COMPANY | $17.1M | 503.9K | 3.15% | — |
| 11 | D DNTH DIANTHUS THERAPEUTICS INC | $15.9M | 163.0K | 2.93% | — |
| 12 | S STT-PG SPDR SERIES TRUST | $15.8M | 100.0K | 2.92% | — |
| 13 | D DGX QUEST DIAGNOSTICS INC | $13.8M | 65.1K | 2.55% | — |
| 14 | I IONS IONIS PHARMACEUTICALS INC | $11.4M | 144.4K | 2.11% | — |
| 15 | ? N/A EYEPOINT INC | $11M | 767.1K | 2.02% | — |
| 16 | A ALMS ALUMIS INC | $7.8M | 278.5K | 1.45% | — |
| 17 | V VIK VIKING THERAPEUTICS INC | $7.1M | 180.7K | 1.30% | — |
| 18 | C CELC CELCUITY INC | $6.2M | 59.3K | 1.15% | — |
| 19 | C CYTK CYTOKINETICS INC | $6M | 70.7K | 1.11% | — |
| 20 | M MRK MERCK & CO INC | $6M | 46.7K | 1.11% | — |